Altogether, our study emphasizes the key role of RYR1-mediated intracellular Ca2+ mishandling in myogenic differentiation (and to some extent in the motor outcome) in DMD and the potential value of RYR stabilizers as adjunctive therapy in human dystrophinopathies. The gene discussed is RYR2; the disease is Duchenne muscular dystrophy.